Skip to main content
Log in

Are thyroid function tests too frequently and inappropriately requested?

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In spite of data supporting the use of the serum thyrotropin (TSH) concentration as the best test to detect abnormal thyroid function, measurement of circulating thyroid hormones with or without a serum TSH continues to be frequently requested to evaluate thyroid function. We have analyzed how combinations of thyroid function tests were ordered by referring physicians and the results of the tests in order to offer some suggestions as to how to use thyroid function tests in a cost effective manner. During 1995, 19,181 inpatient and outpatient requests (45,865 different tests) for thyroid function tests were received by the laboratory of a 1600 bed University Hospital in Parma, Italy. The following tests were carried out: T4, free T4, T3, free T3 and TSH. Serum TSH values below and above the normal range were considered to reflect abnormal thyroid function i.e. hyperthyroidism, or hypothyroidism including subclinical disease independent of the results of the other tests. Combinations of ordered tests and the percent of the total for each combination were: TSH+T4+T3 (56%), TSH+FT4+FT3 (14%), TSH (12%), TSH+FT4 (9%), TSH+T4 (1%), TSH+T4+T3+FT4+FT3 (5%), others (3%). The T4+T3+TSH panel (10,780 requests) had normal serum TSH values in 80.6% and the FT4+ FT3+TSH panel (2,590 requests) had normal TSH values in 73.2%. Elevated serum TSH concentrations were observed more frequently in hospitalized than in ambulatory patients (9.7% vs 7.4% p<0.001). T3 (elevated serum T3, normal T4 and low TSH concentrations) and T4 (elevated serum T4, normal T3 and low TSH concentrations) toxicosis were observed in 8.1% and 9.4%, respectively, of the requested test (NS). FT3 and FT4 toxicosis, defined as for T3 and T4 toxicosis, were observed in 7.5% and 4.9%, respectively (NS). The low T3 and low FT3 syndrome in hospitalized patients was present in 1.6% and 2.3% of the requests, respectively (NS). The low T4+low T3 and low FT4+low FT3 syndrome was present in only 0.3% and 0.2%, respectively, of the requests. Our study shows that a) in hospitalized patients thyroid function tests were requested in 20% of the patients and only one in 14 of these patients at the highest could have abnormal thyroid function, as indicated by abnormal TSH value b) FT4 (or T4) is as useful as FT3 (or T3) in the diagnosis of hyperthyroidism, c) in hospitalized patients the low T3 syndrome was far less common than that reported in the literature, probably due to the lower severity of illness, d) panels which include T3 and FT3 are not justified, and e) serum TSH alone is the most appropriate initial thyroid function test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stockigt J.R. Serum thyrotropin and thyroid hormone measurements and assessment of thyroid hormone transport. In: Braverman L.E., Utiger R.D. (Eds.), Werner and Ingbar’s The Thyroid, ed. 7. Lippincott-Raven Publ., Philadelphia, 1996, p. 377.

    Google Scholar 

  2. Nolan J.P., Tarsa N.J., DiBenedetto G. Case-finding for unsuspected thyroid disease: Costs and health benefits. Am. J. Clin. Pathol. 83: 346, 1985.

    CAS  PubMed  Google Scholar 

  3. Ferro-Luzzi A., Leclercq C., Berardi D. Sistema informativo nutrizionale. Relazione Scientifica elaborata per il Ministero della Sanità. Istituto Nazionale della Nutrizione, 1992.

    Google Scholar 

  4. Vanderpump M.P.J., Tunbridge M.W.G. The epidemiology of thyroid disease. In: Braverman L.E., Utiger R.D. (Eds.) Werner and Ingbar’s The Thyroid, ed. 7. Lippincott-Raven Publ. Philadelphia, 1996, p. 474.

    Google Scholar 

  5. Lindsay R.S., Toft A.D. Hypothyroidism. Lancet 349: 413, 1997.

    Article  CAS  PubMed  Google Scholar 

  6. Lazarus J.H. Hyperthyroidism. Lancet 349: 339, 1997.

    Article  CAS  PubMed  Google Scholar 

  7. Eggertsen R., Petersen K., Lundberg P.A., Nyström E., Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. Br. Med. J. 297: 1586, 1988.

    Article  CAS  Google Scholar 

  8. Feldkamp C.S., Carey J.L. An algorithmic approach to thyroid function testing in a managed care setting. Am. J. Clin. Pathol. 105: 11, 1996.

    CAS  PubMed  Google Scholar 

  9. Surks M.I., Ocampo E. Subclinical thyroid disease. Am. J. Med. 100: 217, 1990.

    Article  Google Scholar 

  10. Singer P.A., Cooper D.S., Levy E.G., Ladenson P.W., Braverman L.E., Daniels G., Greenspan F.S., McDougall I.R., Nikolai T.F. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 273: 808, 1995.

    Article  CAS  PubMed  Google Scholar 

  11. DeGroot L.J., Mayor G. Admission screening by thyroid function tests in an acute general care teaching hospital. Am. J. Med. 93: 558, 1992.

    Article  CAS  PubMed  Google Scholar 

  12. Bauer D.C., Brown A.N. Sensitive thyrotropin and free thyroxine testing in out-patients. Are both necessary? Arch. Intern. Med. 156: 2333, 1996.

    Article  CAS  PubMed  Google Scholar 

  13. Small M., Buchanan L., Evans R. Value of screening thyroid function in acute medical admission to hospital. Clin. Endocrinol. (Oxf.) 32: 185, 1990.

    Article  CAS  Google Scholar 

  14. John R., Henley R., Lloyd G., Elder G. Evaluation of a new strategy for detection of thyroid dysfunction in the routine laboratory. Clin. Chem. 34: 1110, 1988.

    CAS  PubMed  Google Scholar 

  15. Spencer C., Eigen A., Shen D., Duda M., Qualls S., Weiss S., Nicoloff S. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin. Chem. 33: 1391, 1987.

    CAS  PubMed  Google Scholar 

  16. Bagchi N., Brown T.R., Parish R.P. Thyroid dysfunction in adults over age 55 years: a study in an urban United States community. Arch. Intern. Med. 150: 785, 1990.

    Article  CAS  PubMed  Google Scholar 

  17. Roti E., Gardini E., d’Amato L., Salvi M., Robuschi G., Manfredi A., Dallara G., Pino S., Guazzi A.M., Gnudi A., Braverman L.E. Goiter size and thyroid function in an endemic goiter area in northern Italy. J. Clin. Endocrinol. Metab. 63: 558, 1986.

    Article  CAS  PubMed  Google Scholar 

  18. Sawin C.T., Geller A., Kaplan M.M., Bacharach P., Wilson P.W.F., Hershmann J.M. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch. Intern. Med. 151: 165, 1991.

    Article  CAS  PubMed  Google Scholar 

  19. Ehrmann D.A., Weinberg M., Sarne D.H. Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch. Intern. Med. 149: 369, 1989.

    Article  CAS  PubMed  Google Scholar 

  20. de los Santos E.T., Starich G.H., Mazzaferri E.I. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch. Intern. Med. 149: 526, 1989.

    Article  PubMed  Google Scholar 

  21. Ladenson P.W. Diagnosis of thyrotoxicosis. In: Braverman L.E., Utiger R.D. (Eds.) Werner and Ingbar’s The Thyroid, ed. 7. Lippincott-Raven Publ., Philadelphia, 1996, p. 708.

    Google Scholar 

  22. Wartofsky L., Burman K.D. Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome. Endocr. Rev. 3: 210, 1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roti, E., Gardini, E., Magotti, M.G. et al. Are thyroid function tests too frequently and inappropriately requested?. J Endocrinol Invest 22, 184–190 (1999). https://doi.org/10.1007/BF03343539

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343539

Key-words

Navigation